カテゴリ： GlobalInfoResearch, 世界, 部品/材料

世界のセファロスポリンAPI市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Cephalosporine API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO2510）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO2510
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：化学＆材料
■ ページ数：127
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のセファロスポリンAPI市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

セファロスポリンAPI市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のセファロスポリンAPIの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

セファロスポリンAPI市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・初代、二代目、三代目、四代目

用途別セグメントは次のように区分されます。
・経口、注射

世界のセファロスポリンAPI市場の主要な市場プレーヤーは以下のとおりです。
・Union Chempharma、NCPC、Qilu Antibiotics、Lupin Pharmaceuticals、Hospira、Dhanuka Laboratories、Fukang、Dongying Pharmaceutical、Alkem、SALUBRIS、LIVZON、Hetero Drugs、CSPC、TEVA、Orchid Pharma、Taj Pharmaceuticals、Covalent Laboratories、United Laboratories、Aurobindo、Wockhardt、LKPC、HPGC、Huafangpharm

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、セファロスポリンAPI製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なセファロスポリンAPIメーカーの企業概要、2019年～2022年までのセファロスポリンAPIの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なセファロスポリンAPIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別セファロスポリンAPIの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのセファロスポリンAPIの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのセファロスポリンAPI市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびセファロスポリンAPIの産業チェーンを掲載しています。
・第13、14、15章では、セファロスポリンAPIの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- セファロスポリンAPIの概要
- 種類別分析（2017年vs2021年vs2028年）：初代、二代目、三代目、四代目
- 用途別分析（2017年vs2021年vs2028年）：経口、注射
- 世界のセファロスポリンAPI市場規模・予測
- 世界のセファロスポリンAPI生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Union Chempharma、NCPC、Qilu Antibiotics、Lupin Pharmaceuticals、Hospira、Dhanuka Laboratories、Fukang、Dongying Pharmaceutical、Alkem、SALUBRIS、LIVZON、Hetero Drugs、CSPC、TEVA、Orchid Pharma、Taj Pharmaceuticals、Covalent Laboratories、United Laboratories、Aurobindo、Wockhardt、LKPC、HPGC、Huafangpharm
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：初代、二代目、三代目、四代目
・用途別分析2017年-2028年：経口、注射
・セファロスポリンAPIの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・セファロスポリンAPIのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・セファロスポリンAPIのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・セファロスポリンAPIの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・セファロスポリンAPIの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Cephalosporine API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cephalosporine API market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Oral accounting for % of the Cephalosporine API global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While First Generation segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Cephalosporine API include Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals, and Hospira, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cephalosporine API market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
First Generation
Second Generation
Third Generation
Fourth Generation
Market segment by Application can be divided into
Oral
Injection
The key market players for global Cephalosporine API market are listed below:
Union Chempharma
NCPC
Qilu Antibiotics
Lupin Pharmaceuticals
Hospira
Dhanuka Laboratories
Fukang
Dongying Pharmaceutical
Alkem
SALUBRIS
LIVZON
Hetero Drugs
CSPC
TEVA
Orchid Pharma
Taj Pharmaceuticals
Covalent Laboratories
United Laboratories
Aurobindo
Wockhardt
LKPC
HPGC
Huafangpharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cephalosporine API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cephalosporine API, with price, sales, revenue and global market share of Cephalosporine API from 2019 to 2022.
Chapter 3, the Cephalosporine API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cephalosporine API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Cephalosporine API market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cephalosporine API.
Chapter 13, 14, and 15, to describe Cephalosporine API sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Cephalosporine API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cephalosporine API Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 First Generation
1.2.3 Second Generation
1.2.4 Third Generation
1.2.5 Fourth Generation
1.3 Market Analysis by Application
1.3.1 Overview: Global Cephalosporine API Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oral
1.3.3 Injection
1.4 Global Cephalosporine API Market Size & Forecast
1.4.1 Global Cephalosporine API Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Cephalosporine API Sales in Volume (2017-2028)
1.4.3 Global Cephalosporine API Price (2017-2028)
1.5 Global Cephalosporine API Production Capacity Analysis
1.5.1 Global Cephalosporine API Total Production Capacity (2017-2028)
1.5.2 Global Cephalosporine API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cephalosporine API Market Drivers
1.6.2 Cephalosporine API Market Restraints
1.6.3 Cephalosporine API Trends Analysis
2 Manufacturers Profiles
2.1 Union Chempharma
2.1.1 Union Chempharma Details
2.1.2 Union Chempharma Major Business
2.1.3 Union Chempharma Cephalosporine API Product and Services
2.1.4 Union Chempharma Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 NCPC
2.2.1 NCPC Details
2.2.2 NCPC Major Business
2.2.3 NCPC Cephalosporine API Product and Services
2.2.4 NCPC Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Qilu Antibiotics
2.3.1 Qilu Antibiotics Details
2.3.2 Qilu Antibiotics Major Business
2.3.3 Qilu Antibiotics Cephalosporine API Product and Services
2.3.4 Qilu Antibiotics Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Lupin Pharmaceuticals
2.4.1 Lupin Pharmaceuticals Details
2.4.2 Lupin Pharmaceuticals Major Business
2.4.3 Lupin Pharmaceuticals Cephalosporine API Product and Services
2.4.4 Lupin Pharmaceuticals Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Hospira
2.5.1 Hospira Details
2.5.2 Hospira Major Business
2.5.3 Hospira Cephalosporine API Product and Services
2.5.4 Hospira Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Dhanuka Laboratories
2.6.1 Dhanuka Laboratories Details
2.6.2 Dhanuka Laboratories Major Business
2.6.3 Dhanuka Laboratories Cephalosporine API Product and Services
2.6.4 Dhanuka Laboratories Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Fukang
2.7.1 Fukang Details
2.7.2 Fukang Major Business
2.7.3 Fukang Cephalosporine API Product and Services
2.7.4 Fukang Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Dongying Pharmaceutical
2.8.1 Dongying Pharmaceutical Details
2.8.2 Dongying Pharmaceutical Major Business
2.8.3 Dongying Pharmaceutical Cephalosporine API Product and Services
2.8.4 Dongying Pharmaceutical Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Alkem
2.9.1 Alkem Details
2.9.2 Alkem Major Business
2.9.3 Alkem Cephalosporine API Product and Services
2.9.4 Alkem Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 SALUBRIS
2.10.1 SALUBRIS Details
2.10.2 SALUBRIS Major Business
2.10.3 SALUBRIS Cephalosporine API Product and Services
2.10.4 SALUBRIS Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 LIVZON
2.11.1 LIVZON Details
2.11.2 LIVZON Major Business
2.11.3 LIVZON Cephalosporine API Product and Services
2.11.4 LIVZON Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Hetero Drugs
2.12.1 Hetero Drugs Details
2.12.2 Hetero Drugs Major Business
2.12.3 Hetero Drugs Cephalosporine API Product and Services
2.12.4 Hetero Drugs Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 CSPC
2.13.1 CSPC Details
2.13.2 CSPC Major Business
2.13.3 CSPC Cephalosporine API Product and Services
2.13.4 CSPC Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 TEVA
2.14.1 TEVA Details
2.14.2 TEVA Major Business
2.14.3 TEVA Cephalosporine API Product and Services
2.14.4 TEVA Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Orchid Pharma
2.15.1 Orchid Pharma Details
2.15.2 Orchid Pharma Major Business
2.15.3 Orchid Pharma Cephalosporine API Product and Services
2.15.4 Orchid Pharma Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Taj Pharmaceuticals
2.16.1 Taj Pharmaceuticals Details
2.16.2 Taj Pharmaceuticals Major Business
2.16.3 Taj Pharmaceuticals Cephalosporine API Product and Services
2.16.4 Taj Pharmaceuticals Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Covalent Laboratories
2.17.1 Covalent Laboratories Details
2.17.2 Covalent Laboratories Major Business
2.17.3 Covalent Laboratories Cephalosporine API Product and Services
2.17.4 Covalent Laboratories Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 United Laboratories
2.18.1 United Laboratories Details
2.18.2 United Laboratories Major Business
2.18.3 United Laboratories Cephalosporine API Product and Services
2.18.4 United Laboratories Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Aurobindo
2.19.1 Aurobindo Details
2.19.2 Aurobindo Major Business
2.19.3 Aurobindo Cephalosporine API Product and Services
2.19.4 Aurobindo Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Wockhardt
2.20.1 Wockhardt Details
2.20.2 Wockhardt Major Business
2.20.3 Wockhardt Cephalosporine API Product and Services
2.20.4 Wockhardt Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 LKPC
2.21.1 LKPC Details
2.21.2 LKPC Major Business
2.21.3 LKPC Cephalosporine API Product and Services
2.21.4 LKPC Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 HPGC
2.22.1 HPGC Details
2.22.2 HPGC Major Business
2.22.3 HPGC Cephalosporine API Product and Services
2.22.4 HPGC Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Huafangpharm
2.23.1 Huafangpharm Details
2.23.2 Huafangpharm Major Business
2.23.3 Huafangpharm Cephalosporine API Product and Services
2.23.4 Huafangpharm Cephalosporine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Cephalosporine API Breakdown Data by Manufacturer
3.1 Global Cephalosporine API Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Cephalosporine API Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Cephalosporine API
3.4 Market Concentration Rate
3.4.1 Top 3 Cephalosporine API Manufacturer Market Share in 2021
3.4.2 Top 6 Cephalosporine API Manufacturer Market Share in 2021
3.5 Global Cephalosporine API Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Cephalosporine API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cephalosporine API Market Size by Region
4.1.1 Global Cephalosporine API Sales in Volume by Region (2017-2028)
4.1.2 Global Cephalosporine API Revenue by Region (2017-2028)
4.2 North America Cephalosporine API Revenue (2017-2028)
4.3 Europe Cephalosporine API Revenue (2017-2028)
4.4 Asia-Pacific Cephalosporine API Revenue (2017-2028)
4.5 South America Cephalosporine API Revenue (2017-2028)
4.6 Middle East and Africa Cephalosporine API Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Cephalosporine API Sales in Volume by Type (2017-2028)
5.2 Global Cephalosporine API Revenue by Type (2017-2028)
5.3 Global Cephalosporine API Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Cephalosporine API Sales in Volume by Application (2017-2028)
6.2 Global Cephalosporine API Revenue by Application (2017-2028)
6.3 Global Cephalosporine API Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Cephalosporine API Sales by Type (2017-2028)
7.2 North America Cephalosporine API Sales by Application (2017-2028)
7.3 North America Cephalosporine API Market Size by Country
7.3.1 North America Cephalosporine API Sales in Volume by Country (2017-2028)
7.3.2 North America Cephalosporine API Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Cephalosporine API Sales by Type (2017-2028)
8.2 Europe Cephalosporine API Sales by Application (2017-2028)
8.3 Europe Cephalosporine API Market Size by Country
8.3.1 Europe Cephalosporine API Sales in Volume by Country (2017-2028)
8.3.2 Europe Cephalosporine API Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Cephalosporine API Sales by Type (2017-2028)
9.2 Asia-Pacific Cephalosporine API Sales by Application (2017-2028)
9.3 Asia-Pacific Cephalosporine API Market Size by Region
9.3.1 Asia-Pacific Cephalosporine API Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Cephalosporine API Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Cephalosporine API Sales by Type (2017-2028)
10.2 South America Cephalosporine API Sales by Application (2017-2028)
10.3 South America Cephalosporine API Market Size by Country
10.3.1 South America Cephalosporine API Sales in Volume by Country (2017-2028)
10.3.2 South America Cephalosporine API Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cephalosporine API Sales by Type (2017-2028)
11.2 Middle East & Africa Cephalosporine API Sales by Application (2017-2028)
11.3 Middle East & Africa Cephalosporine API Market Size by Country
11.3.1 Middle East & Africa Cephalosporine API Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Cephalosporine API Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Cephalosporine API and Key Manufacturers
12.2 Manufacturing Costs Percentage of Cephalosporine API
12.3 Cephalosporine API Production Process
12.4 Cephalosporine API Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Cephalosporine API Typical Distributors
13.3 Cephalosporine API Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Cephalosporine API Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Cephalosporine API Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Union Chempharma Basic Information, Manufacturing Base and Competitors
Table 4. Union Chempharma Major Business
Table 5. Union Chempharma Cephalosporine API Product and Services
Table 6. Union Chempharma Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. NCPC Basic Information, Manufacturing Base and Competitors
Table 8. NCPC Major Business
Table 9. NCPC Cephalosporine API Product and Services
Table 10. NCPC Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Qilu Antibiotics Basic Information, Manufacturing Base and Competitors
Table 12. Qilu Antibiotics Major Business
Table 13. Qilu Antibiotics Cephalosporine API Product and Services
Table 14. Qilu Antibiotics Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Lupin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Lupin Pharmaceuticals Major Business
Table 17. Lupin Pharmaceuticals Cephalosporine API Product and Services
Table 18. Lupin Pharmaceuticals Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Hospira Basic Information, Manufacturing Base and Competitors
Table 20. Hospira Major Business
Table 21. Hospira Cephalosporine API Product and Services
Table 22. Hospira Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Dhanuka Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Dhanuka Laboratories Major Business
Table 25. Dhanuka Laboratories Cephalosporine API Product and Services
Table 26. Dhanuka Laboratories Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Fukang Basic Information, Manufacturing Base and Competitors
Table 28. Fukang Major Business
Table 29. Fukang Cephalosporine API Product and Services
Table 30. Fukang Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Dongying Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Dongying Pharmaceutical Major Business
Table 33. Dongying Pharmaceutical Cephalosporine API Product and Services
Table 34. Dongying Pharmaceutical Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Alkem Basic Information, Manufacturing Base and Competitors
Table 36. Alkem Major Business
Table 37. Alkem Cephalosporine API Product and Services
Table 38. Alkem Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. SALUBRIS Basic Information, Manufacturing Base and Competitors
Table 40. SALUBRIS Major Business
Table 41. SALUBRIS Cephalosporine API Product and Services
Table 42. SALUBRIS Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. LIVZON Basic Information, Manufacturing Base and Competitors
Table 44. LIVZON Major Business
Table 45. LIVZON Cephalosporine API Product and Services
Table 46. LIVZON Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table 48. Hetero Drugs Major Business
Table 49. Hetero Drugs Cephalosporine API Product and Services
Table 50. Hetero Drugs Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. CSPC Basic Information, Manufacturing Base and Competitors
Table 52. CSPC Major Business
Table 53. CSPC Cephalosporine API Product and Services
Table 54. CSPC Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. TEVA Basic Information, Manufacturing Base and Competitors
Table 56. TEVA Major Business
Table 57. TEVA Cephalosporine API Product and Services
Table 58. TEVA Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Orchid Pharma Basic Information, Manufacturing Base and Competitors
Table 60. Orchid Pharma Major Business
Table 61. Orchid Pharma Cephalosporine API Product and Services
Table 62. Orchid Pharma Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Taj Pharmaceuticals Major Business
Table 65. Taj Pharmaceuticals Cephalosporine API Product and Services
Table 66. Taj Pharmaceuticals Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Covalent Laboratories Basic Information, Manufacturing Base and Competitors
Table 68. Covalent Laboratories Major Business
Table 69. Covalent Laboratories Cephalosporine API Product and Services
Table 70. Covalent Laboratories Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. United Laboratories Basic Information, Manufacturing Base and Competitors
Table 72. United Laboratories Major Business
Table 73. United Laboratories Cephalosporine API Product and Services
Table 74. United Laboratories Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 76. Aurobindo Major Business
Table 77. Aurobindo Cephalosporine API Product and Services
Table 78. Aurobindo Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 80. Wockhardt Major Business
Table 81. Wockhardt Cephalosporine API Product and Services
Table 82. Wockhardt Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. LKPC Basic Information, Manufacturing Base and Competitors
Table 84. LKPC Major Business
Table 85. LKPC Cephalosporine API Product and Services
Table 86. LKPC Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. HPGC Basic Information, Manufacturing Base and Competitors
Table 88. HPGC Major Business
Table 89. HPGC Cephalosporine API Product and Services
Table 90. HPGC Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Huafangpharm Basic Information, Manufacturing Base and Competitors
Table 92. Huafangpharm Major Business
Table 93. Huafangpharm Cephalosporine API Product and Services
Table 94. Huafangpharm Cephalosporine API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 95. Global Cephalosporine API Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kiloton)
Table 96. Global Cephalosporine API Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 97. Market Position of Manufacturers in Cephalosporine API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 98. Global Cephalosporine API Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 99. Head Office and Cephalosporine API Production Site of Key Manufacturer
Table 100. Cephalosporine API New Entrant and Capacity Expansion Plans
Table 101. Cephalosporine API Mergers & Acquisitions in the Past Five Years
Table 102. Global Cephalosporine API Sales by Region (2017-2022) & (Kiloton)
Table 103. Global Cephalosporine API Sales by Region (2023-2028) & (Kiloton)
Table 104. Global Cephalosporine API Revenue by Region (2017-2022) & (USD Million)
Table 105. Global Cephalosporine API Revenue by Region (2023-2028) & (USD Million)
Table 106. Global Cephalosporine API Sales by Type (2017-2022) & (Kiloton)
Table 107. Global Cephalosporine API Sales by Type (2023-2028) & (Kiloton)
Table 108. Global Cephalosporine API Revenue by Type (2017-2022) & (USD Million)
Table 109. Global Cephalosporine API Revenue by Type (2023-2028) & (USD Million)
Table 110. Global Cephalosporine API Price by Type (2017-2022) & (US$/Ton)
Table 111. Global Cephalosporine API Price by Type (2023-2028) & (US$/Ton)
Table 112. Global Cephalosporine API Sales by Application (2017-2022) & (Kiloton)
Table 113. Global Cephalosporine API Sales by Application (2023-2028) & (Kiloton)
Table 114. Global Cephalosporine API Revenue by Application (2017-2022) & (USD Million)
Table 115. Global Cephalosporine API Revenue by Application (2023-2028) & (USD Million)
Table 116. Global Cephalosporine API Price by Application (2017-2022) & (US$/Ton)
Table 117. Global Cephalosporine API Price by Application (2023-2028) & (US$/Ton)
Table 118. North America Cephalosporine API Sales by Country (2017-2022) & (Kiloton)
Table 119. North America Cephalosporine API Sales by Country (2023-2028) & (Kiloton)
Table 120. North America Cephalosporine API Revenue by Country (2017-2022) & (USD Million)
Table 121. North America Cephalosporine API Revenue by Country (2023-2028) & (USD Million)
Table 122. North America Cephalosporine API Sales by Type (2017-2022) & (Kiloton)
Table 123. North America Cephalosporine API Sales by Type (2023-2028) & (Kiloton)
Table 124. North America Cephalosporine API Sales by Application (2017-2022) & (Kiloton)
Table 125. North America Cephalosporine API Sales by Application (2023-2028) & (Kiloton)
Table 126. Europe Cephalosporine API Sales by Country (2017-2022) & (Kiloton)
Table 127. Europe Cephalosporine API Sales by Country (2023-2028) & (Kiloton)
Table 128. Europe Cephalosporine API Revenue by Country (2017-2022) & (USD Million)
Table 129. Europe Cephalosporine API Revenue by Country (2023-2028) & (USD Million)
Table 130. Europe Cephalosporine API Sales by Type (2017-2022) & (Kiloton)
Table 131. Europe Cephalosporine API Sales by Type (2023-2028) & (Kiloton)
Table 132. Europe Cephalosporine API Sales by Application (2017-2022) & (Kiloton)
Table 133. Europe Cephalosporine API Sales by Application (2023-2028) & (Kiloton)
Table 134. Asia-Pacific Cephalosporine API Sales by Region (2017-2022) & (Kiloton)
Table 135. Asia-Pacific Cephalosporine API Sales by Region (2023-2028) & (Kiloton)
Table 136. Asia-Pacific Cephalosporine API Revenue by Region (2017-2022) & (USD Million)
Table 137. Asia-Pacific Cephalosporine API Revenue by Region (2023-2028) & (USD Million)
Table 138. Asia-Pacific Cephalosporine API Sales by Type (2017-2022) & (Kiloton)
Table 139. Asia-Pacific Cephalosporine API Sales by Type (2023-2028) & (Kiloton)
Table 140. Asia-Pacific Cephalosporine API Sales by Application (2017-2022) & (Kiloton)
Table 141. Asia-Pacific Cephalosporine API Sales by Application (2023-2028) & (Kiloton)
Table 142. South America Cephalosporine API Sales by Country (2017-2022) & (Kiloton)
Table 143. South America Cephalosporine API Sales by Country (2023-2028) & (Kiloton)
Table 144. South America Cephalosporine API Revenue by Country (2017-2022) & (USD Million)
Table 145. South America Cephalosporine API Revenue by Country (2023-2028) & (USD Million)
Table 146. South America Cephalosporine API Sales by Type (2017-2022) & (Kiloton)
Table 147. South America Cephalosporine API Sales by Type (2023-2028) & (Kiloton)
Table 148. South America Cephalosporine API Sales by Application (2017-2022) & (Kiloton)
Table 149. South America Cephalosporine API Sales by Application (2023-2028) & (Kiloton)
Table 150. Middle East & Africa Cephalosporine API Sales by Region (2017-2022) & (Kiloton)
Table 151. Middle East & Africa Cephalosporine API Sales by Region (2023-2028) & (Kiloton)
Table 152. Middle East & Africa Cephalosporine API Revenue by Region (2017-2022) & (USD Million)
Table 153. Middle East & Africa Cephalosporine API Revenue by Region (2023-2028) & (USD Million)
Table 154. Middle East & Africa Cephalosporine API Sales by Type (2017-2022) & (Kiloton)
Table 155. Middle East & Africa Cephalosporine API Sales by Type (2023-2028) & (Kiloton)
Table 156. Middle East & Africa Cephalosporine API Sales by Application (2017-2022) & (Kiloton)
Table 157. Middle East & Africa Cephalosporine API Sales by Application (2023-2028) & (Kiloton)
Table 158. Cephalosporine API Raw Material
Table 159. Key Manufacturers of Cephalosporine API Raw Materials
Table 160. Direct Channel Pros & Cons
Table 161. Indirect Channel Pros & Cons
Table 162. Cephalosporine API Typical Distributors
Table 163. Cephalosporine API Typical Customers
List of Figures
Figure 1. Cephalosporine API Picture
Figure 2. Global Cephalosporine API Revenue Market Share by Type in 2021
Figure 3. First Generation
Figure 4. Second Generation
Figure 5. Third Generation
Figure 6. Fourth Generation
Figure 7. Global Cephalosporine API Revenue Market Share by Application in 2021
Figure 8. Oral
Figure 9. Injection
Figure 10. Global Cephalosporine API Revenue, (USD Million) & (Kiloton): 2017 & 2021 & 2028
Figure 11. Global Cephalosporine API Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Cephalosporine API Sales (2017-2028) & (Kiloton)
Figure 13. Global Cephalosporine API Price (2017-2028) & (US$/Ton)
Figure 14. Global Cephalosporine API Production Capacity (2017-2028) & (Kiloton)
Figure 15. Global Cephalosporine API Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Cephalosporine API Market Drivers
Figure 17. Cephalosporine API Market Restraints
Figure 18. Cephalosporine API Market Trends
Figure 19. Global Cephalosporine API Sales Market Share by Manufacturer in 2021
Figure 20. Global Cephalosporine API Revenue Market Share by Manufacturer in 2021
Figure 21. Cephalosporine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Cephalosporine API Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Cephalosporine API Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Cephalosporine API Sales Market Share by Region (2017-2028)
Figure 25. Global Cephalosporine API Revenue Market Share by Region (2017-2028)
Figure 26. North America Cephalosporine API Revenue (2017-2028) & (USD Million)
Figure 27. Europe Cephalosporine API Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Cephalosporine API Revenue (2017-2028) & (USD Million)
Figure 29. South America Cephalosporine API Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Cephalosporine API Revenue (2017-2028) & (USD Million)
Figure 31. Global Cephalosporine API Sales Market Share by Type (2017-2028)
Figure 32. Global Cephalosporine API Revenue Market Share by Type (2017-2028)
Figure 33. Global Cephalosporine API Price by Type (2017-2028) & (US$/Ton)
Figure 34. Global Cephalosporine API Sales Market Share by Application (2017-2028)
Figure 35. Global Cephalosporine API Revenue Market Share by Application (2017-2028)
Figure 36. Global Cephalosporine API Price by Application (2017-2028) & (US$/Ton)
Figure 37. North America Cephalosporine API Sales Market Share by Type (2017-2028)
Figure 38. North America Cephalosporine API Sales Market Share by Application (2017-2028)
Figure 39. North America Cephalosporine API Sales Market Share by Country (2017-2028)
Figure 40. North America Cephalosporine API Revenue Market Share by Country (2017-2028)
Figure 41. United States Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Cephalosporine API Sales Market Share by Type (2017-2028)
Figure 45. Europe Cephalosporine API Sales Market Share by Application (2017-2028)
Figure 46. Europe Cephalosporine API Sales Market Share by Country (2017-2028)
Figure 47. Europe Cephalosporine API Revenue Market Share by Country (2017-2028)
Figure 48. Germany Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Cephalosporine API Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Cephalosporine API Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Cephalosporine API Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Cephalosporine API Revenue Market Share by Region (2017-2028)
Figure 57. China Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Cephalosporine API Sales Market Share by Type (2017-2028)
Figure 64. South America Cephalosporine API Sales Market Share by Application (2017-2028)
Figure 65. South America Cephalosporine API Sales Market Share by Country (2017-2028)
Figure 66. South America Cephalosporine API Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Cephalosporine API Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Cephalosporine API Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Cephalosporine API Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Cephalosporine API Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Cephalosporine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Cephalosporine API in 2021
Figure 78. Manufacturing Process Analysis of Cephalosporine API
Figure 79. Cephalosporine API Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のセファロスポリン市場2022年：市場規模予測（～2028年）
  • 世界の弾道繊維素材市場2022年：市場規模予測（～2028年）
  • 世界の農業用キトサン市場2022年：市場規模予測（～2028年）
  • 世界の金触媒市場2022年：市場規模予測（～2028年）
  • 世界のセルロースフィルム市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO2510 )"世界のセファロスポリンAPI市場2022年：市場規模予測（～2028年）" (英文：Global Cephalosporine API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。